News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Xcel Pharmaceuticals, Inc. Pulls IPO Plan, Cites Market Conditions; $75 Million


10/19/2005 5:10:50 PM

Xcel Pharmaceuticals Inc., which markets drugs for epilepsy and migraines, on Friday pulled plans for its initial public offering, citing market conditions.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES